| Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 331.05M | 319.15M | 349.00M | 368.50M | 344.75M |
| Gross Profit | 27.50M | 17.77M | 29.36M | 48.35M | 51.53M |
| EBITDA | 39.14M | -61.46M | 2.98M | 86.45M | 71.46M |
| Net Income | -69.13M | -137.34M | -104.07M | -39.10M | -36.34M |
Balance Sheet | |||||
| Total Assets | 1.94B | 2.04B | 2.52B | 2.89B | 2.94B |
| Cash, Cash Equivalents and Short-Term Investments | 231.28M | 370.69M | 564.49M | 866.27M | 1.14B |
| Total Debt | 784.74M | 873.18M | 950.33M | 1.10B | 1.25B |
| Total Liabilities | 1.44B | 1.43B | 1.44B | 1.57B | 1.58B |
| Stockholders Equity | 707.78M | 799.22M | 958.09M | 1.12B | 1.15B |
Cash Flow | |||||
| Free Cash Flow | 118.02M | 114.26M | 110.30M | 95.17M | 101.41M |
| Operating Cash Flow | 118.02M | 136.91M | 148.01M | 128.64M | 126.26M |
| Investing Cash Flow | -28.17M | -296.51M | -244.69M | -58.88M | -294.41M |
| Financing Cash Flow | -84.66M | -166.19M | -94.15M | -442.72M | 526.75M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | HK$576.01M | 5.37 | 3.64% | 6.03% | -7.06% | -38.60% | |
70 Outperform | HK$1.71B | 4.09 | 2.82% | ― | 7.38% | 37.96% | |
66 Neutral | $17.65B | 18.10 | 5.60% | 3.62% | 6.62% | 11.55% | |
55 Neutral | HK$689.50M | 3.87 | 3.62% | ― | -7.09% | -25.68% | |
50 Neutral | HK$428.64M | -2.93 | -21.61% | ― | ― | ― | |
43 Neutral | HK$259.20M | -0.62 | -36.69% | ― | -56.43% | 57.59% | |
42 Neutral | HK$139.61M | -0.04 | -514.90% | ― | -15.27% | -18.83% |